Osteoporosis and bone density clinic marketing: screening pages, DXA and heel scans, bone claims and supplements

An osteoporosis or bone density clinic is found by a woman in her sixties whose primary care clinician suggested a scan, by someone who just broke a wrist in a minor fall, by a patient on long-term steroid medicine who was told to watch their bones, and by a gynecologist or primary care office looking for a place to send patients for testing and follow-up. Osteoporosis has no symptoms until a bone breaks, so the page has to explain a test and a risk to people who feel fine. Who should the page say needs a scan? What can a heel scan at a health fair tell someone? Can the clinic say it rebuilds bone or reverses osteoporosis, and what can it say about the calcium and vitamin D products on its shelf? This guide covers what the U.S. Preventive Services Task Force, NIAMS, MedlinePlus, Medicare and the FDA say, and the federal advertising, referral and privacy rules that shape a bone health clinic’s pages.

Four related topics have their own guides and are not repeated here. Hormone, thyroid and diabetes care are covered in our guide to endocrinology practice marketing. Hormone therapy claims after menopause are covered in our guide to menopause clinic marketing. Free screenings, event sign-up forms and what a screening event can promise are covered in our guide to health fair and screening event marketing. Selling supplements from a practice is covered in our guide to selling supplements in a medical practice. This guide covers what is specific to an osteoporosis or bone density clinic. Bone density claims for vibration devices are covered in our guide to whole body vibration marketing claims.

What USPSTF, NIAMS and MedlinePlus say about osteoporosis and screening

A bone health page starts with what osteoporosis is, who the screening recommendation covers and what the test measures. The sources describe it this way:

• The USPSTF final recommendation statement Osteoporosis to Prevent Fractures: Screening (published January 14, 2025) recommends screening for osteoporosis to prevent osteoporotic fractures in women 65 years or older (grade B) and in postmenopausal women younger than 65 years who are at increased risk for an osteoporotic fracture as estimated by clinical risk assessment (grade B). For men, it concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening (I statement). It says the recommendations apply to adults 40 years or older without known osteoporosis or a history of fragility fractures, and that screening includes DXA bone mineral density, with or without fracture risk assessment.
• The NIAMS page Osteoporosis (last reviewed December 2022) calls osteoporosis a silent disease because there are no symptoms until a bone is broken, and lists sex, age, body size, race, family history, hormone changes, diet, other medical conditions and certain medications among the factors that may increase risk.
• The NIAMS page Osteoporosis: Diagnosis, Treatment, and Steps to Take (last reviewed December 2022) says the goals for treating osteoporosis are to slow or stop bone loss and to prevent fractures, and that treatment may include nutrition, exercise, fall prevention and medications.
• The MedlinePlus Osteoporosis topic page (last updated September 30, 2025) says anyone can develop osteoporosis, that it is more likely with one or more risk factors, and that for men it is not clear yet whether regular screening is helpful.
• The MedlinePlus Bone Density Scan test page (last updated July 8, 2024) says a DEXA or DXA scan is a low-dose x-ray that measures calcium and other minerals in the bones, and that it is used to diagnose osteopenia and osteoporosis, predict the risk of future fractures and see if treatment is working.

Two points shape the marketing. First, the patient feels well, so the page has to explain why a test matters without scaring people into it and without telling everyone over a certain age that they need one. Second, a scan result is a number that needs a clinician to explain it, so the page has to say who reads the scan, who talks the patient through the result and how the referring clinician hears back.

Screening pages: who the recommendation covers

Patients search for “bone density test near me”, “DEXA scan” and “osteoporosis screening”. A screening page should say who the national recommendation covers in the words USPSTF uses: women 65 or older, and postmenopausal women younger than 65 who are at increased risk as estimated by a clinical risk assessment. For men, it should say that the Task Force found the evidence insufficient to recommend for or against screening, and that a man who wonders about his bones should talk with his clinician. A page that tells every adult over 50 to book a scan goes beyond the recommendation.

Check the date on each source a page cites. The NIAMS diagnosis page (last reviewed December 2022) still describes the earlier screening wording, and the 2025 USPSTF statement is the current recommendation. Cite USPSTF for who to screen, give its published date, and recheck it when the Task Force posts an update.

Phrases that need rewriting:

• “Everyone over 50 needs a bone scan”. USPSTF names women 65 or older and postmenopausal women younger than 65 at increased risk. Quote the recommendation and invite others to ask their clinician.
• “Men need screening too, book today”. USPSTF found the evidence insufficient for men. Say that, and say a man can discuss his risk with his clinician.
• “Find out before it’s too late”. Fear copy is out of place. Say that osteoporosis has no symptoms until a bone breaks, as NIAMS puts it, and what the test measures.

Explaining the scan and the result

A scan page answers what the test is, how it feels, how long it takes and who explains the result. MedlinePlus describes a central DEXA scan with the patient lying on a padded table, and says results are given as T-scores or Z-scores, with T-scores used for postmenopausal women and men age 50 or older. NIAMS ranks DXA at the hip and spine above other methods for diagnosing osteoporosis and predicting fracture risk, and says a doctor may recommend lifestyle approaches and medications when bone density is below a certain level.

So the page can describe the scan, the low-dose x-ray, what a T-score is and that a clinician explains what the number means for that patient. It should not suggest that the scan alone decides treatment, and it should not post a table that tells patients to self-diagnose from a printout. Name the clinician who reads the scan and the one who talks with the patient, with their credentials. Who may perform a bone density scan and who may read it are set state by state.

Phrases that need rewriting:

• “Painless scan, instant diagnosis”. Describe the scan as MedlinePlus does, and say who reviews the images and when the patient hears the result.
• “Know your fracture risk in 10 minutes”. Say what the scan measures and that a clinician puts the result together with the patient’s history.
• “Zero radiation worries”. MedlinePlus calls it a low-dose x-ray. Use that wording.

Heel scans and screening events

A portable heel or wrist scan at a pharmacy, a senior center or a health fair is a familiar outreach tool for a bone clinic. The NIAMS diagnosis page says peripheral DXA measures bone density in the wrist and heel and is portable, that a doctor may recommend a quantitative ultrasound of the heel, and that if a heel ultrasound indicates bone loss, the person will still need a DXA test to diagnose bone loss and osteoporosis. MedlinePlus says a peripheral scan cannot give as much detail as a central DEXA scan and that a provider may recommend a central scan if the person is found to be at risk. The USPSTF 2025 statement reviewed evidence for central DXA only.

That shapes the event flyer and the result card. Call a heel scan a screening check, not a diagnosis, and say on the card that a central DXA scan is needed to diagnose osteoporosis. Do not tell a person at an event that they have osteoporosis, or that their bones are fine. Say how to follow up with their own clinician or with the clinic. Sign-up forms, free offers and what an event may collect are covered in our guide to health fair and screening event marketing.

Phrases that need rewriting:

• “Free heel scan tells you if you have osteoporosis”. NIAMS says a DXA test is still needed to diagnose. Call it a screening check and give the follow-up step.
• “Your bones are healthy” on an event result card. Say what the check measured and that it does not rule out osteoporosis.
• “Low score? Book your treatment today” on the card. Say that a low result is a reason to talk with a clinician about a full scan.

Medicare coverage on the page

The Medicare.gov page Bone mass measurements (checked October 30, 2026) says Part B covers bone mass measurements once every 24 months, or at a shorter interval if medically necessary, if the person meets one or more conditions it lists: a woman whose doctor determines she is estrogen-deficient and at risk for osteoporosis, X-rays that show possible osteoporosis, osteopenia or vertebral fractures, taking prednisone or steroid-type drugs or planning to begin, a diagnosis of primary hyperparathyroidism, or being monitored to see if osteoporosis drug therapy is working. It says the patient pays nothing for the test if the doctor or other provider accepts assignment.

So “Medicare covers your bone scan” on its own overstates it. Say that Medicare Part B covers the test for people who meet the listed conditions, at the stated interval, and link to Medicare.gov. Say whether the clinic accepts assignment, and tell patients to ask about other costs before the visit. Medicare marketing rules for the wider practice are in our guide to marketing to Medicare patients.

Treatment claims: rebuild, reverse and cure

NIAMS says the goals of treatment are to slow or stop bone loss and to prevent fractures. It also says that for older adults, exercise no longer increases bone mass, and that exercise helps them build muscle, strength, coordination and balance, which can lower the chance of falling. Those words support a page that describes a care plan and fall prevention. They do not support headlines about rebuilding bone, reversing osteoporosis, curing it or getting the bones of a younger person.

Under 15 U.S.C. 45, deceptive acts or practices in commerce are unlawful, and 15 U.S.C. 52 prohibits false advertisements likely to induce the purchase of drugs, devices, services or cosmetics. The FTC staff Health Products Compliance Guidance says claims about the health benefits or safety of health-related products require competent and reliable scientific evidence, and that an advertiser is responsible for the claims its ads convey, including implied ones. A rise in a patient’s T-score or a fracture rate is a results claim. Leave numbers off the page unless counsel has reviewed the substantiation and the page quotes and attributes the source.

Medicines belong in the clinician’s conversation with the patient, not on an ad. Do not name a medicine or a dose on a marketing page, do not promise a patient a prescription, and do not run down a treatment the patient may already take. A page can say that the clinic discusses treatment options, including medicines where appropriate, along with nutrition, exercise and fall prevention.

Phrases that need rewriting:

• “Reverse your osteoporosis”. NIAMS describes goals to slow or stop bone loss and prevent fractures. Describe the care plan, not a reversal.
• “Rebuild bone with our exercise program”. NIAMS says exercise no longer increases bone mass in older adults and helps with strength and balance. Say that.
• “Drug-free bone cure”. There is no cure claim to make. Say what the program includes and that a clinician reviews treatment options.
• “Ask about the injection that builds new bone”. Leave medicine names and promises off the page. Say the clinic discusses treatment options at the visit.

Calcium, vitamin D and products on the shelf

NIAMS says calcium and vitamin D are important nutrients for preventing osteoporosis, and tells patients to talk to their health care provider about the type and amount of supplements they should take. That supports advice given at a visit. It does not turn a product sold in the clinic into a treatment.

The FDA page Questions and Answers on Dietary Supplements (content current as of August 27, 2026) says the FDA does not approve dietary supplements or their labeling before they are marketed, that a product sold as a dietary supplement and represented explicitly or implicitly to treat, prevent or cure a specific disease meets the definition of a drug, and that a structure/function claim on a label needs substantiation and the disclaimer that the product is not intended to diagnose, treat, cure or prevent any disease. So a shop page that says a bone supplement treats or prevents osteoporosis turns it into a drug claim. Our guide to selling supplements in a medical practice covers conflicts of interest and the rest of the rules.

Phrases that need rewriting:

• “Our bone formula prevents osteoporosis”. The FDA treats a disease claim for a supplement as a drug claim. Leave it out.
• “Doctor-formulated, FDA-approved calcium”. The FDA says it does not approve dietary supplements before they are marketed. Leave approval wording off.
• “Stop your bone loss naturally”. Say what the product contains and that patients should ask their clinician what to take.

A hip fracture can lead to joint surgery: NIAMS says a person may need a hip replacement after breaking a hip in a fall or from a bone disease. If your clinic works with a surgeon or joint program, describe the hand-off plainly and follow our guide to joint replacement marketing for how that program presents surgery, recovery and implants.

Referrals from primary care and gynecology

A bone clinic relies on referrals from primary care, gynecology, rheumatology, orthopedics and fracture care, and its outreach to them is where the federal referral rules apply. Under 42 U.S.C. 1320a-7b(b), the federal anti-kickback statute, it is a crime to knowingly and willfully offer, pay, solicit or receive any remuneration to induce or reward referrals of items or services payable by a federal health care program. Rules on referral fees and fee splitting are also set state by state. Our guide to patient and physician referrals covers the general rules. For a bone clinic, keep these points:

• Do not pay, discount, place a free scanner in, share staff with, or give gifts to a referring office in return for patients without counsel’s review.
• Referral materials say who the clinic sees, what to send, how the scan report and the consult note come back, and who to call.
• A fracture liaison or follow-up program for patients who broke a bone runs through the referring clinician and the patient’s own consent, not through a bought list.
• Practices that see Medicaid patients follow the rules in our guide to marketing to Medicaid patients.

Privacy, pixels and ads

A booking for a bone density scan reveals a health concern, and a form that asks about fractures, steroid use or menopause collects health details. Keep those bookings and page clicks out of tracking pixels and ad platform tools unless a written agreement covers them; our guide to tracking pixels on practice websites covers the setup. The Google Ads personalized advertising policy lists health among its sensitive interest categories and restricts targeting based on it. Public ads can target by place and by search terms, and they should never be built from the practice’s patient list or an event sign-up sheet.

Under 45 CFR 164.501, a communication about a covered entity’s own treatment for an individual, such as a reminder that a follow-up scan is due, can fall outside the definition of marketing, while a mailing that promotes a third party’s product, such as a supplement brand, generally needs a signed authorization under 45 CFR 164.508. Check the reminder program with counsel before it goes out.

Patient stories

A patient who stayed active after a diagnosis makes a strong story, and it is one person’s result. Under 16 CFR 255.2, an ad that shows one person’s result on a key attribute is likely to be read as what others will generally achieve, unless the practice has substantiation for that or clearly and conspicuously discloses what people can generally expect. A before and after T-score is a result. Get the patient’s signed authorization under 45 CFR 164.508 where the practice is a covered entity, and leave out medicines and diagnoses the patient has not chosen to share. Our guide to testimonials and before and after photos covers the full rules.

Illustration: two bone density clinic pages

Illustration: a page reads “Everyone over 50 is at risk. Our free heel scan tells you in minutes if you have osteoporosis. Our program reverses bone loss without drugs, and our clinic-only calcium formula prevents fractures. Medicare covers it all. Enter your fractures, medicines and Medicare number to book.” It widens the screening recommendation, treats a heel scan as a diagnosis, makes reversal and disease claims, overstates Medicare coverage and collects health details through a booking form.

Illustration: a second page for the same clinic reads “Osteoporosis has no symptoms until a bone breaks. The U.S. Preventive Services Task Force recommends screening for women 65 or older and for postmenopausal women younger than 65 at increased risk; if you are a man or are unsure, ask your clinician. A central DXA scan is a low-dose x-ray of the hip and spine. [Clinician name, license] reads your scan, and [Physician name] talks with you about the result and a plan that may include nutrition, exercise, fall prevention and medicines where appropriate. Medicare Part B covers the test for people who meet certain conditions; see Medicare.gov. Call [phone] to book; we will ask about your history and insurance by phone.” It quotes the recommendation, describes the scan, names who reads and explains it, makes no promises and keeps health details off the web form.

Checklist before the bone density page goes live

• The screening page quotes the USPSTF recommendation with its published date, and says what it found for men.
• The scan page describes a central DXA scan as a low-dose x-ray and names who performs it, who reads it and who explains the result.
• Heel or wrist scans at events are called screening checks, and the result card says a central DXA scan is needed to diagnose.
• Medicare wording matches Medicare.gov: Part B, listed conditions, the interval and assignment.
• No rebuild, reverse or cure claims, no medicine names or doses, and no promise of a prescription.
• Supplements on the shelf carry no disease or approval claims, and patients are told to ask their clinician what to take.
• No payment, free equipment, gift or shared staff with referring offices without counsel’s review.
• Bookings, event sign-ups and page clicks stay out of pixels and ad audiences; no ads from patient lists and no targeting by health status.
• Stories have a signed authorization and a disclosure of what people can generally expect where needed.

For primary care and gynecology practices that find and remind the patients who are due for a scan, our guide to osteoporosis screening outreach covers recall lists, the Medicare 23-month rule and reminder wording.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses, including osteoporosis and bone density clinics. For a bone clinic, that means a site that quotes the screening recommendation with its date, explains the scan and the result in plain words, names each clinician and credential, gives the Medicare wording from Medicare.gov, and gives referring offices a clear way to send a patient, plus booking and event forms that keep fractures, medicines and insurance numbers off the web and away from tracking tools. We do not decide how care is delivered; your clinicians do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• USPSTF: Osteoporosis to Prevent Fractures: Screening (published January 14, 2025)
• Medicare.gov: Bone mass measurements (checked October 30, 2026)
• NIAMS: Osteoporosis (last reviewed December 2022)
• NIAMS: Osteoporosis: Diagnosis, Treatment, and Steps to Take (last reviewed December 2022)
• MedlinePlus: Osteoporosis (last updated September 30, 2025)
• MedlinePlus: Bone Density Scan (last updated July 8, 2024)
• FDA: Questions and Answers on Dietary Supplements (content current as of August 27, 2026)
• 15 U.S.C. 45: Unfair methods of competition unlawful
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• 42 U.S.C. 1320a-7b: Criminal penalties for acts involving Federal health care programs
• 45 CFR 164.501: Definitions
• 45 CFR 164.508: Uses and disclosures for which an authorization is required
• 16 CFR 255.2: Consumer endorsements
• Google Ads: Personalized advertising policy

More in Physician specialty marketing